LettinoMLeonardiSDe MariaEet al.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease. Eur J Prev Cardiol2017; 24: 61–70.
2.
SchieleFEcarnotFChopardR. Coronary artery disease: risk stratification and patient selection for more aggressive secondary prevention. Eur J Prev Cardiol2017; 24: 88–100.
3.
Kedhi E. DAPT STEMI: a randomized trial of 6-month vs. 12-month DAPT after DES implantation in STEMI. TCTMD 2017.
4.
HahnJ-YSongYBOhJ-Het al.6-Month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. Lancet2018; 391: 1274–1284.
5.
FeresFCostaRAAbizaidAet al.Three vs. twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial. JAMA2013; 310: 2510–2522.
6.
GwonHCHahnJYParkKWet al.Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation2012; 125: 505–513.
7.
HanYXuBXuKet al.Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 Trial. Circ Cardiovasc Interv2016; 9: e003145–e003145.
8.
HongSJShinDHKimJSet al.6-Month versus 12-month dual-antiplatelet therapy following long everolimus-eluting stent implantation: the IVUS-XPL Randomized Clinical Trial. JACC Cardiovasc Interv2016; 9: 1438–1446.
9.
KimBKHongMKShinDHet al.A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). JACC2012; 60: 1340–1348.
10.
Schulz-SchupkeSByrneRATen BergJMet al.ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J2015; 36: 1252–1263.
11.
ValgimigliMCampoGMontiMet al.Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation2012; 125: 2015–2026.
12.
Toth-ZsambokiEHorvathZHajtmanLet al.Cardiac rehabilitation programme as a non-pharmacological platelet inhibitory tool in acute coronary syndrome survivors. Eur J Prev Cardio2017; 24: 1148–1156.
